Spermatogenesis: occurs in spermatic tubules, mitosis (spermatogonia to spermatocytes), meiosis x2 (primary spermatocytes to secondary spermatocytes to spermatids), spermiogenesis (spermatids to spermatozoa)
Maturation: occurs in epididymis, acquire mobility and capacity to fertilize, completed at epididymal tail (stored here)
Capacitation: activation of sperm's ability to fertilize egg, only occurs in female genital tract
Hypermobility: increased mobility occurs after capacitation (only in female genital tract)
Acrosome reaction: head of sperm releases enzymes to dissolve the outer layer of ovum
Normal male ejaculation
Controlled by spinal ejaculatory center (T12-L2)
Emission: sympathetic mediated, bladder neck contraction, release of fluid into posterior urethra (stimulates urethral-muscle reflex)
Expulsion: activated by urethral-muscle reflex, contraction of bulbospongiosus/ischiocavernosus, mediated by pudendal nerve
Azoospermia workup, from Campbell's
Infertility Workup
Timing
Wait 1yr before starting workup, 6mo if woman > 35yo
75% can achieve pregnancy within 6mo trying, 85% within 12mo, 90% within 2yr
30% male infertility will be identified as idiopathic
Both partners need to undergo workup
Consider if 2+ pregnancy losses or failed artificial reproduction cycles
History
Prior pregnancies and childbirth: some men may have had prior children
Ejaculate frequency: semen parameters peak after 1-2 days, then decline - no benefit in abstaining for long periods to "build up" semen
Intercourse: timing, frequency
Comorbidities: higher risk of infertility with HTN, HLD, obesity, DM, hypo/hyperthyroidism
No association with infertility: caffeine, cell phones
Medical Causes
TICS: Toxins, Infections/inflammation, Childhood history, Sexual history
Neurologic: DM, SCI, and MS all affect normal ejaculation
Cancer: can negatively affect sperm parameters even prior to treatment, testis cancer has even greater effect
Hyperthermia: cryptorchidism, heated seats, and laptop heat should be avoided
Infections: can cause strictures, prostatitis, testis failure, pre-pubertal mumps does not affect fertility, wait 3mo after febrile illness to check semenalysis
Medical risk factors: liver failure, DM, thyroid disorders
Hydrocele: increased prevalence in infertile patients but unclear cause and unclear benefit to performing hydrocelectomy
Kartagener syndrome: nonmotile cilia prevent sperm motility, also have bronchiectasis, sinusitis, situs inversus, diagnose with evaluation of axoneme
Young syndrome: thick epididymal secretions obstruct the vas, may also have bronchiectasis and sinusitis
Cystic fibrosis: absent vas, bronchiectasis, sinusitis, pancreatic disease, evaluate with CFTR panel
Congenital bilateral absence of vas deferens (CBAVD): isolated absence of vas (no URI symptoms)
Surgical Causes
RPLND: results in retrograde ejaculation
Hernia repair: can obstruct vas deferens or testicular blood supply, 1-2% vs 0.3% pediatric vs adult repair
Pediatric inguinal surgery: testis atrophy develops in 0.3%
5ARi: questionable effect on semen parameters, can consider stopping
Anabolic steroids: inhibits LH, withdrawal can take months/years to reverse
Illicit drugs: marijuana may decrease tesosterone, alcohol converts T to E, tobacco may affect sperm parameters, cocaine has questionable effects
Antipsychotics: antidopamine effect leads to elevated prolactin
Opioids: suppress LH at the hypothalamic level
Chemotherapy: can lead to DNA damage at 2yrs after administration, mainly platinum-based, alkylating agents, antimetabolites, vinca alkaloids, topoisomerase inhibitors
Antibiotics: tetracycline can be directly spermatotoxic, nitrofurantoin may have negative temporary effect
Sulfasalazine: leads to oligoasthenospermai, can switch to mesalazine
Environmental/Occupational exposure: heavy metals, pesticides, hyperthermia
Physical Exam
Secondary sexual characteristics: pubic hair, gynecomastia, arm span > 5cm height
Obesity: increased aromatase conversion to estradiol
Genital exam: location/size of testes, presence of varicocele, palpable vas deferens, abnormal urethral appearance
DRE: optional, SVs not normally palpable
Lab Evaluation
Semenalysis
Highly variable, check minimum 2 separated by 2-4 weeks
Abstain from ejaculation for 24hrs (not more) to provide optimal sample
Volume: consider workup if < 1.0-1.5mL
Density: oligospermia (< 13.5million/mL) and cryptozoospermia (so few it's hard to measure)
Total #: volume x density (normal > 39mil)
Motility: asthenospermia (normal > 32%)
Morphology: teratospermia (overabundance of abnormal forms), globospermia (lacking acrosomes) normal > 4%
Vitality: necrospermia (large number nonliving sperm), normal > 58%
Antisperm antibodies: due to injury of blood/testis barrier, suspect if sperm agglutination or decreased motility, seen in vasectomy, testis trauma, orchitis, cryptorchidism, testis cancer, varicocele
Pyospermia: > 1million/mL, may cause injury secondary to reactive oxygen species, Pap smear will differentiate WBCs from immature germ cells
Indications: not required for every patient, obtain if concern for impaired libido, erectile dysfunction, oligozoospermia, azoospermia, atrophic testes, or abnormal physical exam
Testosterone: normal > 280-300, 55+% should be bioavailable (check albumin + SHBG), peaks in the morning
LH/FSH: sertoli dysfunction indicated by elevated FSH, testicular dysfunction indicated by elevated LH
Estrogen: T/E ratio < 10 may indicate testicular dysfunction
Prolactin: consider testing if infertility associated with visual field changes, headaches, or ED, repeat if elevated level (large variation)
Hypergonadotropic hypogonadism: elevated LH/FSH with low T, indicates testicular dysfunction
Solitary testis: may demonstrate normal semen parameters and testosterone level but relatively higher level of FSH/LH than would be considered normal due to pituitary response
Azoospermia
Obstructive: likely cause in 96% of patients with FSH < 7.6 and testis > 4.6cm
Nonobstructive: likely cause in 89% of patients with FSH > 7.6 and testis < 4.6cm
Biopsy: not indicated for initial workup, consider if indeterminate findings
References
AUA Core Curriculum
Niederberger, C., S. Ohlander, and R. Pagani. "Male Infertility." Campbell-Walsh Urology 12 (2020).
Schlegel, Peter N., et al. "Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline." (2020).
Tradewell, Michael B., et al. "Evaluation of reproductive parameters in men with solitary testis." The Journal of urology 205.4 (2021): 1153-1158.
Wieder JA: Pocket Guide to Urology. Sixth Edition. J.Wieder Medical: Oakland, CA, 2021.